Neurofibromatosis Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Clinical Trials

Tolerability of Device Based Therapies for Neurofibromatosis Type 1 Cutaneous Neurofibromas
Condition:   Cutaneous Neurofibroma Interventions:   Drug: Kybella;   Device: 980nm laser;   Device: 755nm Alexandrite Laser;   Device: Radiofrequency Sponsors:   Massachusetts General Hospital;   Johns Hopkins University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 29, 2021 Category: Research Source Type: clinical trials